Aya A M Mohammed
Overview
Explore the profile of Aya A M Mohammed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
45
Followers
0
Related Specialties
Related Specialties
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suaifan G, Mohammed A, Alkhawaja B
Molecules
. 2022 Mar;
27(5).
PMID: 35268759
Development of novel derivatives to rein in and fight bacteria have never been more demanding, as microbial resistance strains are alarmingly increasing. A multitude of new fluoroquinolones derivatives with an...
2.
Suaifan G, Alkhawaja B, Mohammed A
Mini Rev Med Chem
. 2021 Apr;
22(4):617-628.
PMID: 33888048
Coronaviruses are RNA-infective viruses that could be considered principal players in universal high-profile outbreaks, namely the Severe Acute Respiratory Syndrome (SARS, 2002-2003), the Middle East Respiratory Syndrome (MERS, 2012) and...
3.
Mohammed A, Suaifan G, Shehadeh M, Okechukwu P
Eur J Med Chem
. 2020 Jul;
202:112513.
PMID: 32623216
Herein we report the design, synthesis and biological evaluation of structurally modified ciprofloxacin, norfloxacin and moxifloxacin standard drugs, featuring amide functional groups at C-3 of the fluoroquinolone scaffold. In vitro...
4.
Suaifan G, Mohammed A
Bioorg Med Chem
. 2019 Sep;
27(21):115072.
PMID: 31537435
No abstract available.
5.
Suaifan G, Mohammed A
Bioorg Med Chem
. 2019 Jun;
27(14):3005-3060.
PMID: 31182257
Fluoroquinolones are considered one of the widely utilized antibiotics, specifically, with the recent development of newer generations such as moxifloxacin, delafloxacin and finafloxacin which possess a wider spectrum of activity...
6.
Mohammed A, Suaifan G, Shehadeh M, Okechukwu P
Drug Dev Res
. 2018 Dec;
80(1):179-186.
PMID: 30570767
In the quest for discovering potent antimicrobial agents with lower toxicity, we envisioned the design and synthesis of nalidixic acid-D-(+)-glucosamine conjugates. The novel compounds were synthesized and evaluated for their...